PAF ANTAGONISTS BLOCK INDUCTION OF NITRIC OXIDE SYNTHASE IN CULTURED MACROPHAGES AND VASCULAR SMOOTH MUSCLE CELLS
- 1 July 1995
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 22 (6-7) , 452-454
- https://doi.org/10.1111/j.1440-1681.1995.tb02041.x
Abstract
1. Nitric oxide (NO) synthase inhibitors and Paf antagonists abrogate hypotension in septic shock. The latter may act by blocking intracellular transduction mechanisms in vascular smooth muscle cells and inflammatory cells. We examined the effect of Paf antagonists on expression of inducible NO synthase. 2. A murine macrophage cell line (J774.2) and rat vascular smooth muscle cells (VSMC) were stimulated with lipopolysaccharide (LPS), either alone or in combination with Paf or Paf antagonists, BN 50739 or E-6123. 3. NO synthase activity in J774.2 was measured by the conversion of [3H]L-arginine to [3H]L-citrulline. Nitrite accumulation was measured in the culture medium of J774.2 and VSM. 4. BN 50739 (10 mumol/L and E-6123 (1 mumol#L) both reduced the expression of calcium-independent NO synthase activity and nitrite accumulation, while Paf alone had no effect. 5. Inhibition of NO synthase induction by Paf antagonists might afford therapeutic benefits in the management of septic shock and possibly other cardiovascular disorders.Keywords
This publication has 9 references indexed in Scilit:
- Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury.The Journal of Experimental Medicine, 1994
- Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide.Circulation Research, 1993
- Nitric oxide synthase activities in human myocardiumThe Lancet, 1993
- Protective and pathological roles of nitric oxide in endotoxin shockCardiovascular Research, 1992
- Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.Proceedings of the National Academy of Sciences, 1990
- Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.The Journal of Experimental Medicine, 1987
- Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. studies with paf-receptor antagonist kadsurenoneBiochemical and Biophysical Research Communications, 1985
- Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogsEuropean Journal of Pharmacology, 1983
- The Release of a Platelet-Activating Factor by Stimulated Rabbit NeutrophilsThe Journal of Immunology, 1979